View highlights and coverage from leading international congresses
It was a pleasure to speak to our Expert Faculty member, Dr Gil Y Melmed (Cedars-Sinai Medical Center, Los Angeles, CA, US), around the ADVANCE and MOTIVATE studies, which investigated risankizumab in the treatment of Crohn’s disease. Questions Could you tell us a little about the aims, design and patient populations of the ADVANCE and MOTIVATE […]
Our Expert Faculty member, Dr Gil Y Melmed (Cedars-Sinai Medical Center, Los Angeles, CA, US), spoke with touchIMMUNOLOGY around the rationale for targeting IL-23 in the treatment of Crohn’s disease and the clinical development of risankizumab. Questions What are the limitations of current biologic drugs in the treatment of patients with Crohn’s disease? (0:10) What […]
We were delighted to meet with Kelli Williams (Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA) to discuss the current hot topics in pediatric immunodeficiency. The talk entitled ‘Hot Topics in Pediatric Immunodeficiency‘ was presented as part of a recorded workshop at the American Academy of Allergy, Asthma & Immunology Virtual Annual […]
touchIMMUNOLOGY caught up with Jonathan Bernstein (University of Cincinnati; Bernstein Allergy Group, Bernstein Clinical Research Center, Cincinnati, OH, USA) to discuss the findings from the HELP study, investigating lanadelumab for the prevention of hereditary angioedema (HAE) attacks. The abstract ‘Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Use of Long-Term Prophylaxis: Final […]
touchIMMUNOLOGY caught up with Jonathan Bernstein (University of Cincinnati; Bernstein Allergy Group, Bernstein Clinical Research Center, Cincinnati, OH, USA) to discuss the prevalence of hereditary angioedema, lanadelumab as a treatment option, and the current challenges faced by patients. The abstract ‘Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Use of Long-Term Prophylaxis: […]
We were delighted to meet with Drew Bird (Associate Professor of Pediatrics, Division of Allergy & Immunology, UT Southwestern Medical Center, Dallas, TX, USA) to discuss the current hot topics in pediatric food allergy. The workshop entitled ‘Hot Topics in Pediatric Food Allergy‘ was presented at the American Academy of Allergy, Asthma & Immunology Virtual […]
Maria Oliva-Hemker (Johns Hopkins University School of Medicine, Baltimore, MD, US) spoke with touchIMMUNOLOGY around recommendations for initiating thiopurine and methotrexate therapy. The presentation ‘Treatment Updates: Where Do Immunomodulators Fit in Current Approaches to Therapy?’ was presented at the virtual 2021 Crohn’s & Colitis Congress. Questions What recommendations do you suggest when initiating thiopurine therapy? […]
It was a pleasure to talk to Maria Oliva-Hemker (Johns Hopkins University School of Medicine, Baltimore, MD, US) around her presentation on ‘Treatment Updates: Where Do Immunomodulators Fit in Current Approaches to Therapy?’ which was presented at the virtual 2021 Crohn’s & Colitis Congress. Questions What has clinical data taught us about the role of […]
We were delighted to catch up with Philippe Bégin (CHU Sainte-Justine, Montréal, Canada) to discuss the use of epicutaneous immunotherapy for peanut allergy. The abstract entitled ‘Reduction in Severity Following 12 Months of Epicutaneous Immunotherapy for Peanut Allergy‘ (ABSTRACT NUMBER: 342) was presented at the American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting, […]
Get the latest clinical insights from touchIMMUNOLOGY
